Impact of COVID-19 pandemic on Legionella testing and infection rates in Ontario
Legionella testing rates decreased by 8% in 2020 and 8% in 2021 and increased by 14% in 2022, which was associated with a decrease in positivity rate only in 2020, at 13%, but not in the other two years. Maintaining vigilance for Legionella testing in future pandemics may support timely diagnosis and treatment, leading to improved patient outcomes. Co-detection of Legionella with SARS-CoV-2 or seasonal respiratory viruses was rare but present during the pandemic. Accordingly, Legionella testing remains essential among high-risk groups, such as the elderly with co-morbidities, critically ill patients, or those with severe or unresponsive pneumonia. Such an approach can aid in differential diagnosis, prompt appropriate treatment, and improve patient outcomes.
Authors
- Jonathan B. Gubbay (ORCID: https://orcid.org/0000-0003-0026-3786)
- Anna Majury
- Adriana Peci (ORCID: https://orcid.org/0000-0002-8624-5775)
- P Zhang
- Ye Li (ORCID: https://orcid.org/0000-0001-7727-0875)
- Ashleigh Sullivan (ORCID: https://orcid.org/0000-0002-7040-2414)
- Yingli Bi
- Allana Murphy
- Keren Leibson
Institutions
- University of British Columbia (CA)
- Public Health Agency of Canada (CA)
- University of Toronto (CA)
- Queen's University (CA)
- Children's & Women's Health Centre of British Columbia (CA)
- Public Health Ontario (CA)
- BC Children's Hospital (CA)
Publication Details
- Journal
- BMC Public Health
- Published
- 2025-10-24
- DOI
- https://doi.org/10.1186/s12889-025-24620-0
- Primary Topic
- Legionella and Acanthamoeba research
- Type
- article
- Field-Weighted Citation Impact
- 0.00